Results 141 to 150 of about 177,264 (261)

The Penile Erection Efficacy of a New Phosphodiesterase Type 5 Inhibitor, Mirodenafil (SK3530), in Rabbits with Acute Spinal Cord Injury

, 2008
Ji‐Youn Jung, Sang‐Ki Kim, Byeong-Soo Kim, Seungho Lee, Young‐Seok Park, Sojung Kim, Changsun Choi, Se-Gyeong Yoon, Jong‐Suk Kim, Sung‐Dae Cho, Gwang-Jin IM, Soomin Lee, Ji‐Won Jung, Yong‐Soon Lee   +13 more
openalex   +2 more sources

The Phosphodiesterase Type 5 Inhibitor Sildenafil Improves DNA Stability and Redox Homeostasis in Systemic Sclerosis Fibroblasts Exposed to Reactive Oxygen Species [PDF]

, 2020
Luigi Di Luigi, Guglielmo Duranti, Ambra Antonioni, Paolo Sgrò, Roberta Ceci, Clara Crescioli, Stefania Sabatini, Andrea Lenzi, Daniela Caporossi, Francesco Del Galdo, Ivan Dimauro, Cristina Antinozzi   +11 more
openalex   +1 more source

Erectile dysfunction and phosphodiesterase type 5 inhibitor use: associations with sexual activities, function and satisfaction in a population sample of older men

, 2015
David M. Lee, James Nazroo, Neil Pendleton   +2 more
openalex   +2 more sources

Comparison of phosphodiesterase type 5 (PDE5) inhibitors.

International journal of clinical practice, 2007
Of the current options available to treat erectile dysfunction, oral phosphodiesterase type 5 (PDE5) inhibitors are the recommended first-line treatment. This review compares the three currently licensed PDE5 inhibitors: sildenafil citrate (sildenafil), vardenafil HCl (vardenafil) and tadalafil.
openaire   +1 more source

Phosphodiesterase type-5 inhibitors for erectile dysfunction following nerve-sparing radical prostatectomy: A network meta-analysis. [PDF]

Medicine (Baltimore), 2021
Yang J, Jian ZY, Wang J.
europepmc   +1 more source

The effect of Phosphodiesterase type 5 inhibitor, Sildenafil and vitamin E on Isoprenaline induced Myocardial Infarction in male Rats. [PDF]

, 2021
Heba S. Youssef, Marwa Muhammad, Mona A. Said   +2 more
openalex   +1 more source

The recent phosphodiesterase type 5 inhibitors

Human Andrology, 2012
Stefan Ückert, Armin J. Becker, Christian G. Stief, Markus A. Kuczyk, Matthias Trottmann   +4 more
openaire   +1 more source

Chronic Low Dosing of Phosphodiesterase Type 5 Inhibitor for Erectile Dysfunction [PDF]

, 2012
Hyun Hwan Sung, Sung Won Lee
openalex   +1 more source

Treatment of Chronic Prostatitis with Phosphodiesterase Type 5 Inhibitors [PDF]

, 2022
Meshari A. Alzahrani, S. Binsaleh, O. Safar, M. Almurayyi, Ahmad Aboukhshaba, B. O. Hakami, S. Albarman, Abdulrahman Alfakhri, R. Almannie   +8 more
openalex   +1 more source

Phosphodiesterase Type 5 Inhibitors and Risk of Skin Cancers in Men: A Meta-Analysis and Trial Sequential Analysis Involving 7,479,852 Subjects. [PDF]

World J Mens Health, 2021
Lu YP, Fan S, Liang Z, Song Y, Liu K, Zhou K, Wang X, Kang J, Yang Y, Liu X.   +9 more
europepmc   +1 more source